Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 6,571 | 6,327 | 5,202 | 4,745 | 5,508 |
| Cost of Goods | 2,507 | 2,130 | 1,177 | 685 | 3,005 |
| Gross Profit | 4,063 | 4,197 | 4,026 | 4,060 | 2,503 |
| Operating Expenses | 11,744 | 13,418 | 13,011 | 10,692 | 8,877 |
| Operating Income | -7,174 | -9,091 | -8,808 | -5,947 | -6,369 |
| Other Income | -13 | -7 | 14 | 12 | 9 |
| Pre-tax Income | -7,186 | -9,098 | -8,795 | -5,935 | -6,360 |
| Net Income Continuous | -7,186 | -9,098 | -8,795 | -5,635 | -6,360 |
| Net Income | $-7,186 | $-9,098 | $-8,795 | $-5,635 | $-6,360 |
| EPS Basic Total Ops | -0.05 | -0.07 | -0.07 | -0.04 | -0.05 |
| EPS Basic Continuous Ops | -0.06 | -0.07 | -0.07 | -0.04 | -0.05 |
| EPS Diluted Total Ops | -0.05 | -0.07 | -0.07 | -0.04 | -0.05 |
| EPS Diluted Continuous Ops | -0.06 | -0.07 | -0.07 | -0.04 | -0.05 |
| EBITDA(a) | $-6,803 | $-8,810 | $-8,569 | $-5,706 | $-6,185 |